BONEH — BBS-Bioactive Bone Substitutes Oyj Cashflow Statement
0.000.00%
- €1.51m
- €6.24m
Annual cashflow statement for BBS-Bioactive Bone Substitutes Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.64 | -2.73 | -2.77 | -3.09 | -3.48 |
Depreciation | |||||
Non-Cash Items | 0.102 | 0.086 | 0.2 | 0.141 | 0.117 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.133 | 0.013 | -0.18 | -0.089 | 0.227 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.44 | -2.42 | -2.52 | -2.82 | -2.92 |
Capital Expenditures | -0.024 | -0.082 | -0.125 | -0.078 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | 0 | — | 0 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.024 | -0.082 | -0.125 | -0.078 | 0 |
Financing Cash Flow Items | — | 0.001 | — | — | 0.05 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.299 | 5.42 | 0.443 | 3.17 | 3.38 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.17 | 2.92 | -2.2 | 0.281 | 0.454 |